USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Note: This document contains side effect information about dexamethasone ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Maxidex.
Applies to dexamethasone ophthalmic: intraocular implant, intraocular suspension
Other dosage forms:
Along with its needed effects, dexamethasone ophthalmic (the active ingredient contained in Maxidex) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking dexamethasone ophthalmic:
Some side effects of dexamethasone ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to dexamethasone ophthalmic: intraocular implant, intraocular suspension, ophthalmic insert, ophthalmic ointment, ophthalmic solution, ophthalmic suspension
The most commonly reported side effects were cataract, elevation of intraocular pressure, and conjunctival hemorrhage.
Very common (10% or more): Cataract (up to 68%), elevation of intraocular pressure (28%), conjunctival hemorrhage (22%)
Common (1% to 10%): Eye pain, conjunctival hyperemia, ocular hypertension, reduced visual acuity, conjunctivitis, vitreous floaters, conjunctival edema, dry eye, vitreous detachment, vitreous opacities, retinal aneurysm, foreign body sensation, corneal erosion, keratitis, anterior chamber inflammation, retinal tear, eyelid ptosis, vitreous detachment, keratoconjunctivitis sicca, corneal staining, photophobia, blurred vision, eye pruritus, increased lacrimation
Rare (less than 0.1%): Burning, stinging
Frequency not reported: Glaucoma with optic nerve damage, visual acuity and visual field defects, subcapsular cataract formation, secondary ocular infection and perforation of the globe
Postmarketing experience: Complication of device insertion (implant misplacement), device dislocation with or without corneal edema, endophthalmitis, hypotony of the eye (associated with vitreous leakage due to injection), retinal detachment
Very common (10% or more): Hypertension (13%)
Common (1% to 10%): Headache
Uncommon (0.1% to 1%): Dysgeusia, migraine
Frequency not reported: Dizziness
Common (1% to 10%): Bronchitis
June 26, 2020
June 25, 2020
June 27, 2020
July 10, 2020
July 9, 2020
July 1, 2020